Who makes Popliteal Plexus Block with 20 ml?

Popliteal Plexus Block with 20 ml is developed by Charlotte Runge.

What development phase is Popliteal Plexus Block with 20 ml in?

Popliteal Plexus Block with 20 ml is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Popliteal Plexus Block with 20 ml

Charlotte Runge · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Popliteal Plexus Block with 20 ml
Sponsor	Charlotte Runge
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effects of 10 Versus 20 mL Local Anesthetic for Popliteal Plexus Block on Opioid Consumption, Pain, and Patient-Reported Outcomes After Total Knee Arthroplasty (PHASE4)
Comparing Classical Approach and Crosswise Approach to Popliteal Sciatic Nerve Block (NA)
Multimodal Analgesia Versus Peripheral Nerve Block for Postoperative Pain Management After Lower Limb Injury Surgery (NA)
The Effect of PPB Using 10, 20 and 30 ml of Lidocaine, Study on Volunteers (PHASE4)
Ultrasound-Guided Popliteal Plexus Block Versus Fascia Iliaca Block After Total Knee Arthroplasty (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Popliteal Plexus Block with 20 ml CI brief — competitive landscape report
Popliteal Plexus Block with 20 ml updates RSS · CI watch RSS
Charlotte Runge portfolio CI